Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruishan Wu

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Frontiers in Microbiology|January 23, 2025
Hotspots and research trends of gut microbiome in polycystic ovary syndrome: a bibliometric analysis (2012-2023)Ruishan Wu, Zhensheng Mai, Xiaoyan Song, et al.
Oncology Letters|January 21, 2016
Expression of Skp2 and p27<sup>kip1</sup> proteins in hypopharyngeal squamous cell carcinoma and its clinical significanceLiansheng Qiu, Jiabao Lv, Yimin Chen, et al.
Frontiers in Endocrinology|May 11, 2026
Integrating bibliometrics and real-world data to map varicocele research and predict surgical outcomesYu Zhou, Shenghui Zhu, Huimin Liang, et al.
IEEE Computer Graphics and Applications|September 26, 2025
Design Exploration of AI-Assisted Personal Affective PhysicalizationRuishan Wu, Zhuoyang Li, Charles Perin, et al.
Open Medicine (Warsaw, Poland)|June 6, 2024
FBXO45 levels regulated ferroptosis renal tubular epithelial cells in a model of diabetic nephropathy by PLK1Bingming Zhu, Yongxuan Hu, Ruishan Wu, et al.
Frontiers in Molecular Biosciences|June 26, 2023
Screening and validation of potential markers associated with uterine corpus endometrial carcinoma and polycystic ovary syndrome based on bioinformatics methodsRuishan Wu, Cailin Wu, Bingming Zhu, et al.
Clinical Pharmacology in Drug Development|January 12, 2020
Single- and Multiple-Dose Safety, Tolerability, and Pharmacokinetic Profiles of ASP8062: Results From 2 Phase 1 StudiesMark Walzer, Gerard J Marek, Ruishan Wu, et al.
Zeitschrift Fur Gesundheitswissenschaften = Journal of Public Health|September 25, 2012
Age variation and sexual dimorphism in the sixteen diagnostic clusters of risk factors for the metabolic syndromeS S Sun, Roy Sabo, S Arslanian, et al.
Journal of Cellular and Molecular Medicine|March 30, 2020
Circular RNA circFBXO11 modulates hepatocellular carcinoma progress and oxaliplatin resistance through miR-605/FOXO3/ABCB1 axisJin Li, Xiaoping Qin, Ruishan Wu, et al.
Molecular Medicine Reports|July 22, 2017
Isorhamnetin inhibits IL‑1β‑induced expression of inflammatory mediators in human chondrocytesJin Li, Ruishan Wu, Xiaoping Qin, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Frontiers in Microbiology|January 23, 2025
Hotspots and research trends of gut microbiome in polycystic ovary syndrome: a bibliometric analysis (2012-2023)Ruishan Wu, Zhensheng Mai, Xiaoyan Song, et al.
Oncology Letters|January 21, 2016
Expression of Skp2 and p27<sup>kip1</sup> proteins in hypopharyngeal squamous cell carcinoma and its clinical significanceLiansheng Qiu, Jiabao Lv, Yimin Chen, et al.
Frontiers in Endocrinology|May 11, 2026
Integrating bibliometrics and real-world data to map varicocele research and predict surgical outcomesYu Zhou, Shenghui Zhu, Huimin Liang, et al.
IEEE Computer Graphics and Applications|September 26, 2025
Design Exploration of AI-Assisted Personal Affective PhysicalizationRuishan Wu, Zhuoyang Li, Charles Perin, et al.
Open Medicine (Warsaw, Poland)|June 6, 2024
FBXO45 levels regulated ferroptosis renal tubular epithelial cells in a model of diabetic nephropathy by PLK1Bingming Zhu, Yongxuan Hu, Ruishan Wu, et al.
Frontiers in Molecular Biosciences|June 26, 2023
Screening and validation of potential markers associated with uterine corpus endometrial carcinoma and polycystic ovary syndrome based on bioinformatics methodsRuishan Wu, Cailin Wu, Bingming Zhu, et al.
Clinical Pharmacology in Drug Development|January 12, 2020
Single- and Multiple-Dose Safety, Tolerability, and Pharmacokinetic Profiles of ASP8062: Results From 2 Phase 1 StudiesMark Walzer, Gerard J Marek, Ruishan Wu, et al.
Zeitschrift Fur Gesundheitswissenschaften = Journal of Public Health|September 25, 2012
Age variation and sexual dimorphism in the sixteen diagnostic clusters of risk factors for the metabolic syndromeS S Sun, Roy Sabo, S Arslanian, et al.
Journal of Cellular and Molecular Medicine|March 30, 2020
Circular RNA circFBXO11 modulates hepatocellular carcinoma progress and oxaliplatin resistance through miR-605/FOXO3/ABCB1 axisJin Li, Xiaoping Qin, Ruishan Wu, et al.
Molecular Medicine Reports|July 22, 2017
Isorhamnetin inhibits IL‑1β‑induced expression of inflammatory mediators in human chondrocytesJin Li, Ruishan Wu, Xiaoping Qin, et al.
Pageof 3